CA2378989A1 - Proteines humaines de domaine lim - Google Patents

Proteines humaines de domaine lim Download PDF

Info

Publication number
CA2378989A1
CA2378989A1 CA002378989A CA2378989A CA2378989A1 CA 2378989 A1 CA2378989 A1 CA 2378989A1 CA 002378989 A CA002378989 A CA 002378989A CA 2378989 A CA2378989 A CA 2378989A CA 2378989 A1 CA2378989 A1 CA 2378989A1
Authority
CA
Canada
Prior art keywords
limd
polynucleotide
polypeptide
sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002378989A
Other languages
English (en)
Inventor
Y. Tom Tang
Henry Yue
Yalda Azimzai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2378989A1 publication Critical patent/CA2378989A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)

Abstract

L'invention concerne des protéines humaines de domaine LIM (LIMD) et des polynucléotides qui identifient et codent LIMD. Cette invention a également trait à des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes, ainsi qu'à des méthodes de diagnostic, de traitement ou de prévention de troubles liés à l'expression du LIMD.
CA002378989A 1999-07-13 2000-07-11 Proteines humaines de domaine lim Abandoned CA2378989A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14342699P 1999-07-13 1999-07-13
US60/143,426 1999-07-13
PCT/US2000/019014 WO2001004308A1 (fr) 1999-07-13 2000-07-11 Proteines humaines de domaine lim

Publications (1)

Publication Number Publication Date
CA2378989A1 true CA2378989A1 (fr) 2001-01-18

Family

ID=22504024

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002378989A Abandoned CA2378989A1 (fr) 1999-07-13 2000-07-11 Proteines humaines de domaine lim

Country Status (5)

Country Link
EP (1) EP1196568A1 (fr)
JP (1) JP2003504060A (fr)
AU (1) AU6091900A (fr)
CA (1) CA2378989A1 (fr)
WO (1) WO2001004308A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005501528A (ja) * 2001-06-05 2005-01-20 エクセリクシス・インコーポレイテッド ｐ５３経路のモディファイヤーとしてのＧＦＡＴｓおよび使用方法
EP1541169A1 (fr) * 2003-12-04 2005-06-15 Aventis Pharma Deutschland GmbH Utilisation de limk-1, ses analogues et ligands pour la préparation d'un medicament contre les thromboses et les embolies
CN113265409B (zh) * 2021-05-21 2022-05-20 北京福君基因生物科技有限公司 Timm21突变基因、检测其的引物、试剂盒和方法以及其用途

Also Published As

Publication number Publication date
EP1196568A1 (fr) 2002-04-17
JP2003504060A (ja) 2003-02-04
AU6091900A (en) 2001-01-30
WO2001004308A1 (fr) 2001-01-18

Similar Documents

Publication Publication Date Title
CA2431493A1 (fr) Aminoacyl arnt synthetases
WO2001005970A2 (fr) Proteines associees de liaison gtp
EP1266001A2 (fr) Facteurs de transcription
EP1196577A2 (fr) Proteines du cycle et de proliferation cellulaires
US20050227277A1 (en) Apoptosis proteins
EP1179065A2 (fr) Molecules completes exprimees dans des tissus humains
WO2000077040A2 (fr) Molecules de signalisation intracellulaires
WO2000078954A2 (fr) Proteines de regulateur de transcription humaines
WO2001019860A2 (fr) Proteines associees a la differenciation cellulaire
EP1244700A2 (fr) Proteines circulant par l'intermediaire de vesicules
US20050048623A1 (en) Cell cycle and proliferation proteins
CA2409392A1 (fr) Proteines de signalisation intracellulaires
CA2378989A1 (fr) Proteines humaines de domaine lim
WO2002048362A2 (fr) Proteines associees a l'embryogenese
CA2336262A1 (fr) Tri de nexines
WO2002046413A2 (fr) Molecules pour la detection et le traitement de maladies
CA2402747A1 (fr) Molecules associees a la proteine g
CA2425767A1 (fr) Lipocalines
CA2375407A1 (fr) Proteines du metabolisme de l'arn
CA2379133A1 (fr) Proteines humaines impliquees dans la detoxification
US20030208040A1 (en) G-protein associated molecules
CA2378116A1 (fr) Molecules de reponse immunologique humaines
US20050059110A1 (en) Human nervous system-associated proteins
CA2417676A1 (fr) Sequences pour l'integrine alpha-8
CA2378930A1 (fr) Proteines de transfert d'electrons

Legal Events

Date Code Title Description
FZDE Dead